Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Screening

News
Test to Assess OUD Risk in Acute Pain Patients Receives FDA Approval
01/03/2024
Tom Valentino, Digital Managing Editor
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by...
01/03/2024
Addiction Professional
News
Carfentanil Re-Emerges: Fentanyl Analog Detected in 12 States
11/02/2023
Tom Valentino, Digital Managing Editor
After being detected once in the US in 2022, carfentanil has been identified in urine drug screenings 35 times in 2023, according to a new Millennium Health report.
After being detected once in the US in 2022, carfentanil has been identified in urine drug screenings 35 times in 2023, according to a new Millennium Health report.
After being detected once in the...
11/02/2023
Addiction Professional
News
Delaware Launches Fentanyl-Xylazine Combo Testing Strip Pilot
06/30/2023
Tom Valentino, Digital Managing Editor
The program will use HarmGuard FX testing strips, which are produced by Delaware-based SIVAD Diagnostic Medical Group.
The program will use HarmGuard FX testing strips, which are produced by Delaware-based SIVAD Diagnostic Medical Group.
The program will use HarmGuard...
06/30/2023
Addiction Professional
News
NIH, FDA Leaders Highlight Need to Improve Drug-Detection Tools
06/12/2023
Tom Valentino, Digital Managing Editor
Leaders from the National Institutes of Health and the US Food and Drug Administration have highlighted the need to address gaps in research, development, and implementation of rapid drug-detecting tools to prevent overdose deaths.
Leaders from the National Institutes of Health and the US Food and Drug Administration have highlighted the need to address gaps in research, development, and implementation of rapid drug-detecting tools to prevent overdose deaths.
Leaders from the National...
06/12/2023
Addiction Professional
News
Study Highlights Prevalence of Buprenorphine “Spiking” in Urine Screenings for OUD Patients
03/28/2023
Tom Valentino, Digital Managing Editor
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples...
03/28/2023
Addiction Professional
News
Fentanyl-Positive Drug Screenings Surge in Western States
02/21/2023
Tom Valentino, Digital Managing Editor
Drug tests positive for fentanyl across the US increased by 146% from 2019 to 2022, largely fueled by the western half of the nation, according to data from the Millennium Health Signals Report, which was released on Tuesday.
Drug tests positive for fentanyl across the US increased by 146% from 2019 to 2022, largely fueled by the western half of the nation, according to data from the Millennium Health Signals Report, which was released on Tuesday.
Drug tests positive for fentanyl...
02/21/2023
Addiction Professional
News
Mental Health, SUD Issues Prevalent Among Nonpsychiatric ER Patients
11/22/2022
Tom Valentino, Digital Managing Editor
About 45% of patients who visit emergency departments for physical injuries and ailments also have mental health and substance use issues, according to researchers at Indiana University.
About 45% of patients who visit emergency departments for physical injuries and ailments also have mental health and substance use issues, according to researchers at Indiana University.
About 45% of patients who visit...
11/22/2022
Addiction Professional
News
Significant Intervention Opportunities Missed in Alcohol-Related Liver Disease Deaths
06/23/2022
Jolynn Tumolo
Numerous chances for care providers to identify alcohol misuse going unnoticed, researchers say.
Numerous chances for care providers to identify alcohol misuse going unnoticed, researchers say.
Numerous chances for care...
06/23/2022
Psych Congress Network
News
Strong Correlation Between Positive Drug Screens and Overdose Deaths, Study Shows
06/20/2022
Tom Valentino, Digital Managing Editor
Findings could facilitate exploration of methods for timely prediction of overdose “hotspots,” researchers say.
Findings could facilitate exploration of methods for timely prediction of overdose “hotspots,” researchers say.
Findings could facilitate...
06/20/2022
Addiction Professional
Ryan Drzewiecki, PsyD, LP
Perspectives
While Often Helpful, Beware of Technology’s Potential for Misuse in Recovery
05/29/2022
Ryan Drzewiecki, PsyD, LP
Key markers of clients’ digital media consumption, including social media, video games, and TV viewing, should be assessed for signs of addiction.
Key markers of clients’ digital media consumption, including social media, video games, and TV viewing, should be assessed for signs of addiction.
Key markers of clients’ digital...
05/29/2022
Addiction Professional

Advertisement

News

News
Test to Assess OUD Risk in Acute Pain Patients Receives FDA Approval
01/03/2024
Tom Valentino, Digital Managing Editor
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by...
01/03/2024
Addiction Professional
News
Carfentanil Re-Emerges: Fentanyl Analog Detected in 12 States
11/02/2023
Tom Valentino, Digital Managing Editor
After being detected once in the US in 2022, carfentanil has been identified in urine drug screenings 35 times in 2023, according to a new Millennium Health report.
After being detected once in the US in 2022, carfentanil has been identified in urine drug screenings 35 times in 2023, according to a new Millennium Health report.
After being detected once in the...
11/02/2023
Addiction Professional
News
Delaware Launches Fentanyl-Xylazine Combo Testing Strip Pilot
06/30/2023
Tom Valentino, Digital Managing Editor
The program will use HarmGuard FX testing strips, which are produced by Delaware-based SIVAD Diagnostic Medical Group.
The program will use HarmGuard FX testing strips, which are produced by Delaware-based SIVAD Diagnostic Medical Group.
The program will use HarmGuard...
06/30/2023
Addiction Professional
News
NIH, FDA Leaders Highlight Need to Improve Drug-Detection Tools
06/12/2023
Tom Valentino, Digital Managing Editor
Leaders from the National Institutes of Health and the US Food and Drug Administration have highlighted the need to address gaps in research, development, and implementation of rapid drug-detecting tools to prevent overdose deaths.
Leaders from the National Institutes of Health and the US Food and Drug Administration have highlighted the need to address gaps in research, development, and implementation of rapid drug-detecting tools to prevent overdose deaths.
Leaders from the National...
06/12/2023
Addiction Professional
News
Study Highlights Prevalence of Buprenorphine “Spiking” in Urine Screenings for OUD Patients
03/28/2023
Tom Valentino, Digital Managing Editor
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples collected in a cross-sectional study showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence.
More than 7% of urine samples...
03/28/2023
Addiction Professional
News
Fentanyl-Positive Drug Screenings Surge in Western States
02/21/2023
Tom Valentino, Digital Managing Editor
Drug tests positive for fentanyl across the US increased by 146% from 2019 to 2022, largely fueled by the western half of the nation, according to data from the Millennium Health Signals Report, which was released on Tuesday.
Drug tests positive for fentanyl across the US increased by 146% from 2019 to 2022, largely fueled by the western half of the nation, according to data from the Millennium Health Signals Report, which was released on Tuesday.
Drug tests positive for fentanyl...
02/21/2023
Addiction Professional
News
Mental Health, SUD Issues Prevalent Among Nonpsychiatric ER Patients
11/22/2022
Tom Valentino, Digital Managing Editor
About 45% of patients who visit emergency departments for physical injuries and ailments also have mental health and substance use issues, according to researchers at Indiana University.
About 45% of patients who visit emergency departments for physical injuries and ailments also have mental health and substance use issues, according to researchers at Indiana University.
About 45% of patients who visit...
11/22/2022
Addiction Professional
News
Significant Intervention Opportunities Missed in Alcohol-Related Liver Disease Deaths
06/23/2022
Jolynn Tumolo
Numerous chances for care providers to identify alcohol misuse going unnoticed, researchers say.
Numerous chances for care providers to identify alcohol misuse going unnoticed, researchers say.
Numerous chances for care...
06/23/2022
Psych Congress Network
News
Strong Correlation Between Positive Drug Screens and Overdose Deaths, Study Shows
06/20/2022
Tom Valentino, Digital Managing Editor
Findings could facilitate exploration of methods for timely prediction of overdose “hotspots,” researchers say.
Findings could facilitate exploration of methods for timely prediction of overdose “hotspots,” researchers say.
Findings could facilitate...
06/20/2022
Addiction Professional
News
Workforce Drug Test Positivity Reaches 20-Year High
04/08/2022
Tom Valentino, Digital Managing Editor
The rate of positive drug test results among American workers in 2021 reached its highest level since 2001, according to data recently published by Quest Diagnostics.
The rate of positive drug test results among American workers in 2021 reached its highest level since 2001, according to data recently published by Quest Diagnostics.
The rate of positive drug test...
04/08/2022
Addiction Professional
News
Vertex Prepares to Submit New Drug Application for Medication to Treat Acute Pain
02/01/2024

Tom Valentino

Tom Valentino
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive results in its Phase 3 program for its selective NaV1.8 inhibitor that was developed as an alternative to opioids for treating moderate-to-severe acute pain, Vertex Pharmaceuticals plans to submit its NDA application...
After announcing positive...
02/01/2024
Addiction Professional
News
Sex Hormone Linked to Cocaine Addiction Susceptibility
01/30/2024
Tom Valentino, Digital Managing Editor
A study from the University of Texas at Arlington backs previous research that shows women are more likely than men to develop an addiction to cocaine, try cocaine at a younger age, use larger amounts of the drug, and suffer an overdose.
A study from the University of Texas at Arlington backs previous research that shows women are more likely than men to develop an addiction to cocaine, try cocaine at a younger age, use larger amounts of the drug, and suffer an overdose.
A study from the University of...
01/30/2024
Addiction Professional
News
Study Finds No Significant Link Between Cannabis Use and Relapse in OUD Patients
01/26/2024

Tom Valentino

Tom Valentino
A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for opioid use...
A recent meta-analysis of 10 longitudinal studies conducted by Yale University researchers found no significant link between cannabis use and relapse on non-medical opioids among patients receiving medication-assisted treatment for opioid use...
A recent meta-analysis of 10...
01/26/2024
Addiction Professional
News
Study Explores Use of DBS to Treat Severe Opioid Use Disorder
01/23/2024

Tom Valentino

Tom Valentino
Allegheny Health Network seeks 2 additional patients for a trial in which patients with treatment-resistant opioid use disorder receive continuous electrical pulses to the brain’s addiction and reward center to curb severe cravings.
Allegheny Health Network seeks 2 additional patients for a trial in which patients with treatment-resistant opioid use disorder receive continuous electrical pulses to the brain’s addiction and reward center to curb severe cravings.
Allegheny Health Network seeks 2...
01/23/2024
Addiction Professional
News
CMS Announces Model to Integrate Behavioral and Physical Healthcare
01/19/2024
Tom Valentino, Digital Managing Editor
The Centers for Medicare & Medicaid Services have introduced a new initiative aimed at advancing the integration of behavioral and physical healthcare, as well as health-related social needs, for people with Medicaid and Medicare.
The Centers for Medicare & Medicaid Services have introduced a new initiative aimed at advancing the integration of behavioral and physical healthcare, as well as health-related social needs, for people with Medicaid and Medicare.
The Centers for Medicare &...
01/19/2024
Behavioral Healthcare Executive
News
FDA-Approved Medication Shows Potential to Reduce Surgery Patients’ Need for Opioids
01/15/2024
Tom Valentino, Digital Managing Editor
Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC)—a drug already approved by the US Food and Drug Administration—may help decrease surgery patients’ pain...
Findings from a recent study conducted by researchers at the Medical University of South Carolina suggest that N-acetylcysteine (NAC)—a drug already approved by the US Food and Drug Administration—may help decrease surgery patients’ pain...
Findings from a recent study...
01/15/2024
Addiction Professional
News
Reduced Drug Use an “Alternative Valid Outcome” for Individuals With Stimulant Use Disorder
01/11/2024
Tom Valentino, Digital Managing Editor
Reducing use of stimulants was associated with significant improvement in health and recovery among individuals with stimulant use disorder—even if they did not achieve total abstinence, according to a new study from NIDA.
Reducing use of stimulants was associated with significant improvement in health and recovery among individuals with stimulant use disorder—even if they did not achieve total abstinence, according to a new study from NIDA.
Reducing use of stimulants was...
01/11/2024
Addiction Professional
News
Costs, Scarcity Remain Problematic for Families Seeking Adolescent Residential Addiction Treatment
01/09/2024
Tom Valentino, Digital Managing Editor
New research from Oregon Health & Science University highlights challenges related to finding residential addiction treatment for adolescents, with medication-assisted treatment options especially scarce.
New research from Oregon Health & Science University highlights challenges related to finding residential addiction treatment for adolescents, with medication-assisted treatment options especially scarce.
New research from Oregon Health...
01/09/2024
Addiction Professional
News
Test to Assess OUD Risk in Acute Pain Patients Receives FDA Approval
01/03/2024
Tom Valentino, Digital Managing Editor
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by AutoGenomics, Inc., is designed for consenting patients at least 18 years of age who are being considered for an opioid prescription of 4 to 30 days.
The AvertD test, developed by...
01/03/2024
Addiction Professional
News
Post-Surgery Opioid Prescribing Decline Continues—but at Slower Pace
12/27/2023
Tom Valentino, Digital Managing Editor
While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.
While prescribing of opioid-containing pain relief medications for surgery patients has declined over the past 7 years, a recent study of pharmacy data by researchers at the University of Michigan shows that decrease has slowed since 2020.
While prescribing of...
12/27/2023
Addiction Professional

Advertisement

Subscribe

Addiction Professional Newsletter

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement